Susquehanna International Group’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,135
Closed -$39.9K 12242
2024
Q2
$39.9K Buy
6,135
+2,885
+89% +$20.1K ﹤0.01% 11494
2024
Q1
$24.1K Buy
3,250
+817
+34% +$6.82K ﹤0.01% 11773
2023
Q4
$20.4K Buy
+2,433
New +$15.3K ﹤0.01% 11973
2023
Q2
Sell
-1,227
Closed -$7.73K 12349
2023
Q1
$7.73K Sell
1,227
-208
-14% -$1.55K ﹤0.01% 12243
2022
Q4
$10K Buy
+1,435
New +$10.1K ﹤0.01% 11936
2022
Q2
Sell
-1,320
Closed -$17K 13162
2022
Q1
$17K Sell
1,320
-3,886
-75% -$52.4K ﹤0.01% 12662
2021
Q4
$85K Sell
5,206
-1,414
-21% -$32.1K ﹤0.01% 12247
2021
Q3
$175K Buy
6,620
+2,214
+50% +$64.6K ﹤0.01% 11636
2021
Q2
$151K Sell
4,406
-1,284
-23% -$50.3K ﹤0.01% 11852
2021
Q1
$287K Buy
5,690
+3,052
+116% +$189K ﹤0.01% 10700
2020
Q4
$124K Buy
2,638
+1,107
+72% +$39K ﹤0.01% 10374
2020
Q3
$61K Buy
+1,531
New +$27.3K ﹤0.01% 10146

Other funds holding EVGN

Susquehanna International Group's EVGN Position: Q3 2024 in Review

Susquehanna International Group sold out of Evogene (EVGN) in Q3 2024, closing a stake of 6,135 shares — an estimated $39.9K sold.

Susquehanna International Group first reported a position in EVGN in Q3 2020 and held it in 12 quarters. The position peaked at $287K in Q1 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • Susquehanna International Group reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 6,135 Evogene shares in Q3 2024, an estimated $39.9K.
  • Susquehanna International Group first reported a position in Evogene in Q3 2020 and held it in 12 quarters.
  • Susquehanna International Group's Evogene position peaked at $287K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.